AI Article Synopsis

  • * The study aims to assess the levels of von Willebrand factor (VWF), ADAMTS13, and their ratio in SCD patients in Calabar to understand their roles in the development of VOC.
  • * Results show that VWF levels were significantly higher in patients experiencing VOC compared to those in steady states and healthy controls, while ADAMTS13 levels did not show significant differences across groups.

Article Abstract

Background: Sickle cell anemia (SCA) is a hypercoagulable state characterized by a significant alteration in hemostatic parameters which may predispose an increased risk of vaso-occlusive crisis (VOC). Sickle cell disease (SCD) is the most common genetic disorder in sub-Saharan Africa. Nigeria bears a high disease burden with an estimated prevalence of 1%-3% of its population being affected by the disease. The study seeks to determine the role of von Willebrand factor (VWF), ADAMTS13, and the ratio of ADAMTS13:VWF antigen in the pathogenesis of VOC.

Objective: The objective of this study is to evaluate the level of VWF, ADAMTS13, and their ratio in SCD subjects in Calabar and to determine their role in the pathogenesis of VOC.

Methodology: This is a comparative study carried out at the University of Calabar Teaching Hospital (UCTH), Calabar. Sixty SCA patients were evaluated in VOC and steady states as well as five parented healthy controls. VWF: Ag and ADAMTS13:Ag were evaluated using Assaypro enzyme-linked immunosorbent assay kits with Lot nos. 01751728 and 04222167R, respectively. Data were analyzed by IBM SPSS Chicago software version 21. The study was approved by the UCTH Institution Ethical Review Board.

Results: The mean ages of the SCA subjects and controls were 23.5 ± 7.2 years and 26.5 ± 5.6 years, respectively (P = 0.706). There were 23 (38.3%) males in the SCA group and 21 (42.0%) females in the controls. There was no significant difference in their sex distribution (P = 0.063). The mean (standard deviation [SD]) of VWF in VOC, steady state, and controls were 2.52 ± 0.34, 1.34 ± 0.23, and 1.41 ± 0.23 IU/mL, respectively. The differences in mean were significantly higher in VOC state (P = 0.003). The mean ± SD of ADAMTS13 in VOC, steady state, and controls were 0.61 ± 0.10, 0.44 ± 0.06, and 0.62 ± 0.10 μg/L, respectively. ADAMTS13 levels did not differ significantly across the groups (P = 0.270). Similarly, there was no significant difference between ADAMTS13:VWF ratios across the groups (P = 0.318).

Conclusion: VWF level is elevated in VOC state and thus may be implicated in the pathogenesis of VOC. ADAMTS13 and the ratio of ADAMTS13:VWF are not significantly affected in VOC.

Download full-text PDF

Source
http://dx.doi.org/10.4103/aam.aam_25_22DOI Listing

Publication Analysis

Top Keywords

adamts13 ratio
16
willebrand factor
12
sickle cell
12
voc steady
12
von willebrand
8
cell disease
8
voc
8
determine role
8
vwf adamts13
8
ratio adamts13vwf
8

Similar Publications

Article Synopsis
  • * The study aims to assess the levels of von Willebrand factor (VWF), ADAMTS13, and their ratio in SCD patients in Calabar to understand their roles in the development of VOC.
  • * Results show that VWF levels were significantly higher in patients experiencing VOC compared to those in steady states and healthy controls, while ADAMTS13 levels did not show significant differences across groups.
View Article and Find Full Text PDF

Investigation of ADAMTS-13 levels in patients with COVID-19 infection.

J Infect Dev Ctries

September 2024

Department of Pediatric Hematology and Oncology, Faculty of Medicine, Usak University, Usak, Turkiye.

Article Synopsis
  • COVID-19 patients have a higher risk of blood clotting issues, possibly linked to ADAMTS-13 levels, a protein that helps regulate blood clotting.
  • A study on 180 patients categorized them into mild and severe COVID-19 groups, comparing their ADAMTS-13 levels with a control group, using various clinical tests.
  • Results showed no significant differences in ADAMTS-13 levels between the groups, suggesting that it may not be a reliable biomarker for assessing patient risk upon admission.
View Article and Find Full Text PDF
Article Synopsis
  • - The study explored immunothrombosis in pneumonia-related acute respiratory distress syndrome (p-ARDS), aiming to understand its profile in both the lungs and the bloodstream among affected patients compared to those with simple pneumonia.
  • - Researchers analyzed samples from 23 p-ARDS patients and 40 pneumonia controls, revealing significant lung inflammation and injury to blood vessel linings in p-ARDS patients, even when accounting for illness severity.
  • - Key findings indicated that inflammatory biomarkers in lung fluid correlated with oxygen levels, while specific serum markers were linked to organ failure and clotting issues, highlighting notable differences in immune responses between the two patient groups.
View Article and Find Full Text PDF

Objective: To analyze the risk factors of percutaneous coronary intervention (PCI) no-reflow in patients with coronary heart disease (CHD) and construct a predictive nomogram model.

Methods: This retrospective study included 260 patients with CHD who underwent PCI in the Third Affiliated Hospital of Chongqing Medical University from January 2022 to December 2023. The subjects were divided into a PCI no-reflow group (n = 86) and normal reflow group (n = 174) based on thrombolysis in myocardial infarction (TIMI) blood flow grading.

View Article and Find Full Text PDF
Article Synopsis
  • Transplant-associated thrombotic microangiopathy (TA-TMA) is a serious complication of hematopoietic stem cell transplants that causes severe blood-related issues and organ dysfunction due to small blood clots forming in circulation.
  • This study examined changes in von Willebrand factor (VWF) in patients to understand its role in the development of TA-TMA, analyzing plasma samples from 14 patients post-transplant.
  • Results indicated that patients with definite TMA showed unique VWF changes compared to those with probable TMA, highlighting a transition from bleeding risks to clotting tendencies based on VWF multimer profiles and degradation products.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!